MTD:NYE-Mettler-Toledo International Inc (USD)

COMMON STOCK | Diagnostics & Research |

Last Closing

USD 1302.24

Change

+5.07 (+0.39)%

Market Cap

N/A

Volume

0.08M

Analyst Target

USD 865.00
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-30 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
DHR Danaher Corporation

-0.37 (-0.15%)

USD 184.90B
IQV IQVIA Holdings Inc

-0.30 (-0.14%)

USD 41.62B
A Agilent Technologies Inc

+0.26 (+0.20%)

USD 37.78B
LH Laboratory Corporation of Amer..

+2.47 (+1.08%)

USD 19.20B
DGX Quest Diagnostics Incorporated

-0.03 (-0.02%)

USD 17.54B
CRL Charles River Laboratories

-2.61 (-1.42%)

USD 9.64B
QGEN Qiagen NV

+0.41 (+0.98%)

USD 9.38B
VNRX Volitionrx Ltd

+0.01 (+1.17%)

USD 0.07B
ENZ Enzo Biochem Inc

+0.02 (+1.77%)

USD 0.06B
TMO Thermo Fisher Scientific Inc

+2.85 (+0.52%)

N/A

ETFs Containing MTD

MCSE Martin Currie Sustainable.. 5.12 % 0.00 %

-0.24 (-0.25%)

N/A
EPRE 4.58 % 0.00 %

N/A

N/A
IBB iShares Biotechnology ETF 2.78 % 0.47 %

-0.01 (-0.25%)

USD 7.39B
BMED BlackRock Future Health E.. 2.61 % 0.00 %

-0.02 (-0.25%)

USD 4.17M
ASRP:XETRA BNP Paribas Easy ECPI Glo.. 2.39 % 0.00 %

-0.07 (-0.25%)

N/A
XMLC:F L&G Clean Water UCITS ETF 2.27 % 0.00 %

-0.11 (-0.25%)

N/A
XLVE:CA Mulvihill U.S. Health Car.. 1.82 % 0.00 %

-0.02 (-0.25%)

N/A
ZUH:CA BMO Equal Weight US Healt.. 1.69 % 0.39 %

+0.10 (+-0.25%)

CAD 0.26B
ZHU:CA BMO Equal Weight US Healt.. 1.69 % 0.00 %

+0.05 (+-0.25%)

CAD 0.01B
HECO SPDR Galaxy Hedged Digita.. 0.00 % 0.95 %

-0.43 (-0.25%)

N/A
QRI:CA 0.00 % 1.06 %

N/A

N/A
YXM.B:CA 0.00 % 0.69 %

N/A

N/A
MJJ 0.00 % 0.00 %

N/A

N/A
MJO 0.00 % 0.00 %

N/A

N/A
DWEQ 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.36% 85% B 55% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.36% 85% B 59% D-
Trailing 12 Months  
Capital Gain 34.32% 85% B 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 34.32% 85% B 75% C
Trailing 5 Years  
Capital Gain 82.34% 92% A 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 82.34% 92% A 82% B
Average Annual (5 Year Horizon)  
Capital Gain 16.38% 92% A 78% C+
Dividend Return 16.38% 92% A 75% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 30.62% 38% F 34% F
Risk Adjusted Return 53.51% 85% B 70% C-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.